Literature DB >> 15057977

Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome.

Carolyn Schanen1, Elisa J F Houwink, Naghmeh Dorrani, Jane Lane, Ruth Everett, Alice Feng, Rita M Cantor, Alan Percy.   

Abstract

Since the identification of mutations in MECP2 in girls and women with apparent Rett syndrome, numerous efforts have been made to develop phenotype-genotype correlations. These studies have produced conflicting results in part related to use of different clinical severity scales, different diagnostic criteria, and different stratification by age and mutation group as well as the possible effects of unbalanced X-chromosome inactivation. The present study applied a revised ordinal scoring system that allowed for correction for patient ages. We analyzed 85 patients with mutation in MECP2. Sixty-five (76%) had one of eight common mutations. Patients with missense mutations had lower total severity scores and better language performance than those with nonsense mutations. No difference was noted between severity scores for mutations in the methyl-binding domain (MBD) and the transcriptional repression domain (TRD). However, patients with missense mutations in TRD had the best overall scores and better preservation of head growth and language skills. Analysis of specific mutation groups demonstrated a striking difference for patients with the R306C mutation including better overall score, later regression, and better language with less motoric impairment. Indeed, these patients as a group accounted for the differences in overall scores between the missense and nonsense groups. Thus, the impact of specific mutations coupled with possible variation in X-chromosome inactivation must be considered carefully in the derivation of phenotype-genotype correlations. These results emphasize the limitations of such analyses in larger mutation groups, either by type or position. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057977     DOI: 10.1002/ajmg.a.20571

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  52 in total

1.  Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2.

Authors:  A Saxena; D de Lagarde; H Leonard; S L Williamson; V Vasudevan; J Christodoulou; E Thompson; P MacLeod; D Ravine
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

Review 2.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

3.  The association between behavior and genotype in Rett syndrome using the Australian Rett Syndrome Database.

Authors:  Laila Robertson; Sonĵa E Hall; Peter Jacoby; Carolyn Ellaway; Nick de Klerk; Helen Leonard
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

Review 4.  Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology.

Authors:  Mohan Gomathi; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-03-02

5.  Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome.

Authors:  D Hettiarachchi; N F Neththikumara; B A P S Pathirana; V H W Dissanayake
Journal:  J Autism Dev Disord       Date:  2020-01

6.  The relationship between MECP2 mutation type and health status and service use trajectories over time in a Rett syndrome population.

Authors:  Deidra Young; Ami Bebbington; Nick de Klerk; Carol Bower; Lakshmi Nagarajan; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2011-01

Review 7.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

Review 8.  The molecular pathology of Rett syndrome: synopsis and update.

Authors:  Schahram Akbarian; Yan Jiang; Genevieve Laforet
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 9.  Autism-lessons from the X chromosome.

Authors:  Elysa J Marco; David H Skuse
Journal:  Soc Cogn Affect Neurosci       Date:  2006-12       Impact factor: 3.436

10.  Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.

Authors:  Matthew J Lyst; Robert Ekiert; Daniel H Ebert; Cara Merusi; Jakub Nowak; Jim Selfridge; Jacky Guy; Nathaniel R Kastan; Nathaniel D Robinson; Flavia de Lima Alves; Juri Rappsilber; Michael E Greenberg; Adrian Bird
Journal:  Nat Neurosci       Date:  2013-06-16       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.